One of the most disturbing aspects of ALS is that it spreads through the body.
Symptoms may begin in one hand, one leg, or the bulbar region and gradually spread to neighboring regions over time. That raises an important question: how does the disease propagate from one group of neurons to another?
One proposed explanation is prion-like spreading.
Not necessarily in the classical infectious sense, but in the sense that abnormal proteins may force normal proteins into the same misfolded state.
Proteins such as TDP-43, SOD1, and FUS can misfold and aggregate. Once aggregates form, they may act as templates that destabilize nearby proteins. A damaged cell may then release abnormal protein fragments, vesicles, or aggregates into the extracellular environment, where neighboring cells absorb them.
The pathology effectively recruits new cells into the same failure mode.
But spreading is probably not just about protein contact alone.
A stressed neuron also changes its environment:
- inflammatory signaling increases
- surrounding glial cells become activated
- oxidative stress rises
- glutamate regulation may worsen
- local metabolic support deteriorates
- mitochondrial damage products accumulate
This means neighboring neurons are no longer operating under normal conditions. Their energy margin shrinks as well.
That may be critical.
A healthy neuron with a large reserve capacity might tolerate some misfolded proteins. But a motor neuron already operating near metabolic limits may not. Once one region becomes unstable, it can create a progressively more hostile environment for connected cells.
The spread may therefore involve both:
- transfer of toxic or misfolded cellular components
- transfer of metabolic stress
Axonal connections may also provide pathways for propagation. Motor neurons are highly interconnected with local support cells, spinal circuits, and long axonal transport systems. Vesicles, damaged mitochondria, RNA-binding proteins, and stress signals can move along these pathways.
In that sense, ALS progression may resemble cascading infrastructure failure more than isolated cell death.
One overloaded node begins failing.
That failure increases stress on neighboring nodes.
Those nodes then begin failing as well.
The outward pattern may appear to be “spreading,” even if the underlying trigger differs among patients.
This may also explain why progression often accelerates after a certain point. Once enough neurons and support systems are impaired, the remaining healthy cells assume a greater compensatory workload while operating in a worsening biochemical environment.
The system loses reserve.
And from that point onward, each new failure makes the next one more likely.
***
ALS pathology does not remain confined to a single neuron. Misfolded proteins, inflammatory signaling, mitochondrial stress, and cellular debris appear to spread dysfunction outward, gradually pulling neighboring cells into the same collapse. TDP-43 pathology behaves less like an isolated defect and more like a propagating process.
That immediately raises an important question: if neurons cannot easily be replaced, could the spread at least be slowed?
One possible approach is to reduce chronic inflammation. Activated microglia and astrocytes are meant to help damaged tissue, but in ALS, they may become part of a self-reinforcing cycle. Inflamed support cells release cytokines, reactive oxygen species, glutamate, and other stress signals, thereby increasing the metabolic burden on already struggling neurons. A motor neuron operating near its energy limit may tolerate normal conditions, but fail once surrounded by inflammatory noise.
The problem is that inflammation is not purely bad. The immune system also clears debris, removes damaged proteins, and supports repair. Completely suppressing it could even worsen the cleanup failure. The real goal would be preventing chronic overactivation without disabling maintenance functions.
This is one reason many ALS interventions appear frustratingly weak. The disease is probably not driven by a single pathway. Protein aggregation, mitochondrial dysfunction, impaired autophagy, excitotoxicity, axonal transport failure, and inflammation all interact. Once enough loops reinforce each other, the system may become self-sustaining.
Still, slowing the spread is important even without a cure. ALS progression is often uneven. Some regions remain functional for years while others fail rapidly. That suggests local conditions influence vulnerability. If the toxic environment around neurons can be made less hostile, remaining cells may survive much longer.
From an energy perspective, anti-inflammatory approaches are plausible because inflammation is metabolically expensive. Immune activation increases oxidative stress, ion-pumping demand, protein turnover, and repair workload. A neuron already struggling to maintain axonal transport over a meter-long axon may simply run out of reserve margin.
The same logic may partly explain why avoiding infections is so important in ALS. Pneumonia, chronic mucus retention, hypoxia, sleep disruption, or repeated aspiration do not merely stress the lungs. They increase whole-body inflammatory signaling and metabolic demand at exactly the moment the nervous system can least afford it.
Unfortunately, current medicine still treats many ALS complications as isolated problems rather than parts of one connected energy and stress network.